Skip to main content
Log in

Continuous or bolus chemotherapy with 5-fluoro-2′-deoxyuridine in transplanted experimental liver tumors?

  • Original Papers
  • Experimental Oncology
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Summary

The effect of continuous and discontinuous locoregional chemotherapy with Floxuridine (FUdR) was studied in a standardized and controlled animal model, using the transplantable Novikoff hepatoma in Sprague-Dawley rats. The liver was perfused after transplantation with a total of 420 mg/kg FUdR, via a fully implanted osmotic minipump or miniport and catheter in the hepatic artery, either continuously (n=22) from day 5 to day 12, or discontinuously (n=28) on days 5 and 8. Viable tumor volume and peritumorous cell infiltration were measured. No reduction in tumor volume was attained using discontinuous therapy, in contrast to a highly significant reduction using continuous therapy (P<0.001). Significantly less cell infiltration was found after discontinuous than after continuous therapy. In conclusion, continuous locoregional chemotherapy with FUdR was the superior administration method on measurable tumor effect, when compared to discontinuous infusion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Aigner KR, Link KH, Stemmler S, Warthona M (1985) Intraartenelle Infusion, experimentelle und pharmakokinetische Grundlagen. Beitr Onkol 21:84–107

    Google Scholar 

  • Balch CM, Urist MM, McGregor ML (1983) Continuous regional chemotherapy for metastatic colorectal cancer using a totally implantable infusion pump. Am J Surg 145:285–290

    Google Scholar 

  • Bartkowski R, Berger MR, Aguiar JLA, Henne TH, Dörsam J, Geelhaar GH, Schlag P, Herfarth C (1986) Experiments on the efficacy and toxicity of locoregional chemotherapy of liver tumors with 5-fluoro-2-deoxyuridien (Fudr) and 5-fluorouracil (5-Fu) in an animal model. Cancer Res Clin Oncol 111:42–46

    Google Scholar 

  • Barone RM, Byfield JE, Goldrarb PB, Frankel S, Ginn C, Greer S (1982) Intra-arterial chemotherapy using an implantable infusion pump and liver irradiation for the treatment of hepatic metastases. Cancer 50:850–862

    Google Scholar 

  • Birns M (1960) An ascites tumor derived from the Novikoff hepatoma. J Natl Cancer Inst 25:547–552

    Google Scholar 

  • Buchwald H, Grage TB, Vassilopoulos PP, Rohde TD, Varco RL, Blackshear PJ (1980) Intraarterial infusion chemotherapy for hepatic carcinoma using a totally implantable infusion pump. Cancer 45:866–869

    Google Scholar 

  • Carlsson G, Gullberg B, Hafström L (1983) Estimation of liver tumor volume using different formulas — an experimental study in rats. J Cancer Res Clin Oncol 105:20–23

    Google Scholar 

  • Cohen AM, Schaeffer N, Higgins J (1986) Treatment of metastatic colorectal cancer with hepatic artery combination chemotherapy. Cancer 57:1115–1117

    Google Scholar 

  • Ensminger WD, Rosowsky A, Raso V, Levin D, Glode M, Come S, Steele G, Frei E (1978) A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2-deoxyuridine and 5-fluorouracil. Cancer Res 38:3784–3792

    Google Scholar 

  • Ensminger W, Niederhuber J, Dakhil S, Thrall J, Wheeler R (1981) Totally implanted drug delivery system for hepatic arterial chemotherapy. Cancer Treat Rep 65:393–400

    Google Scholar 

  • Fraile RJ, Baker LH, Buroker TR, Horwitz J, Vaitkevicius (1980) Pharmacokinetics of 5-fluorouracil administered orally, by rapid intravenous and by slow infusion. Cancer Res 40:2223–2228

    Google Scholar 

  • Haskill S (1983) Tumor immunity and prognosis: the role of mononuclear infiltration. Marcel Dekker, New York

    Google Scholar 

  • Heidelberger C, Danenberg PV, Moran RG (1983) Fluorinated pyrimidines and their nucleosides. Adv Enzymol 54:57–119

    Google Scholar 

  • Hohn DC, Rayner AA, Economou JS, Ignoffo RJ, Lewis BJ, Stagg RJ (1986) Toxicities and complications of implanted pump hepatic arterial and venous floxuridine infusion. Cancer 57:465–470

    Google Scholar 

  • Hottenrott C, Lorenz M (1987) III. International Conference on Advances in Regional Cancer Therapy. ULM (FRG)

  • Kemeny N, Michaelson R (1982) Phase II trial of low dose methotrexate and sequential 5-fluorouracil in the treatment of metastatic colorectal carcinoma. Proc Am Soc Clin Oncol 1:95

    Google Scholar 

  • Kemeny MM, Goldberg DA, Browning S, Metter GE, Miner, Terz JJ (1985) Experience with continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primary. A prospective randomized study. Cancer 55:1265–1270

    Google Scholar 

  • Kufe DW, Egan EM (1981) Enhancement of 5-fluorouracil incorporation into human lymphoblast ribonucleic acid. Biochem Pharmacol 30:129–133

    Google Scholar 

  • Löhrke H, Hesse B (1981) Das Novikoff-Hepatom auf der SD-Ratte. Tumorsteckbrief 3, DKFZ, Heidelberg

    Google Scholar 

  • Lokich (1983) Hepatic artery infusion: Present status and future perspectives. Semin Oncol 10:249–250

    Google Scholar 

  • Lokich J, Bothe A, Fine N (1981) Phase I study of protracted venous infusion of 5-fluorouracil. Cancer 48:2565–2568

    Google Scholar 

  • Moertel CG (1978) Chemotherapy of gastrointestinal cancer. N Engl J Med 299:1049–1052

    Google Scholar 

  • Niederhuber JE, Ensminger W, Gyves J, Thrall, Walker S, Cozzi E (1984) Regional chemotherapy of colorectal cancer metastatic to the liver. Cancer 53:1336–1346

    Google Scholar 

  • Novikoff AB (1957) A transplantable rat liver tumor induced by 4-dimethylaminobenzene. Cancer Res 17:1010–1027

    Google Scholar 

  • Patt YZ, Mavligit GM, Chuang VP, Wallache S, Johnston S, Benjamin RS, Valdivieso M, Hersh EM (1980) Percutaneous hepatic arterial infusion (HAI) of mitomycin C and floxuridine (FUDR): An effective treatment for metastatic colorectal carcinoma in the liver. Cancer 46:261–265

    Google Scholar 

  • Sawyer RC, Stolfi RL, Martin DS, Spiegelman S (1984) Incorporation of 5-fluorouracil into murine bone marrow DNA in vivo. Cancer Res 44:1847–1851

    Google Scholar 

  • Seifert P, Baker L, Reed ML, Vaitkevicius (1975) Comparison of continuous infused 5-fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinoma. Cancer 36:123–128

    Google Scholar 

  • Stagg RJ, Lewis BJ, Friedman MA, Ignoffo RJ, Hohn DC (1984) Hepatic arterial chemotherapy for colorectal cancer metastatic to the liver. Ann Int Med 100:736–743

    Google Scholar 

  • Underwood JCE (1974) Lymphoreticular infiltration in human tumors: prognostic and biological implications: a review. Br J Cancer 30:538–548

    Google Scholar 

  • Weibel ER, Gomex DM (1962) A principle for counting tissue structures on random sections. J Appl Physiol 17:343–346

    Google Scholar 

  • Wilkinson DS, Tlsty TD, Hanas J (1975) The inhibition of ribosomal RNA synthesis and maturation in Novikoff hepatoma cells by 5-fluorouridine. Cancer Res 35:3014–3020

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Riemenschneider, T., Ruf, C., Späth, G. et al. Continuous or bolus chemotherapy with 5-fluoro-2′-deoxyuridine in transplanted experimental liver tumors?. J Cancer Res Clin Oncol 114, 482–486 (1988). https://doi.org/10.1007/BF00391496

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00391496

Key words

Navigation